Belpointe Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-366
| Closed | -$3.85K | – | 2358 |
|
2023
Q1 | $3.85K | Hold |
366
| – | – | ﹤0.01% | 3109 |
|
2022
Q4 | $12.4K | Buy |
+366
| New | +$12.4K | ﹤0.01% | 2496 |
|
2019
Q2 | – | Sell |
-198
| Closed | -$100K | – | 636 |
|
2019
Q1 | $100K | Buy |
+198
| New | +$100K | 0.02% | 449 |
|
2018
Q4 | – | Sell |
-134
| Closed | -$123K | – | 589 |
|
2018
Q3 | $123K | Buy |
+134
| New | +$123K | 0.02% | 588 |
|
2018
Q2 | – | Sell |
-132
| Closed | -$210K | – | 374 |
|
2018
Q1 | $210K | Buy |
+132
| New | +$210K | 0.06% | 305 |
|